10.11.2023 | Marginum News
Almaral, Nostetta Ventures, and Redstone led the investment into Finnish medical technology company Marginum, coupled with Business Finland R&D loan.
22.3.2023 | Marginum News
Marginum Ltd has initiated its first-in-human clinical trials with the aspirate tissue monitor at the Kuopio University Hospital.
21.2.2023 | Tahko Ski Lift Pitch
Tahko Ski Lift Pitch winner Marginum is pioneering optic tissue monitoring with groundbreaking innovation borne from multidisciplinary UEF research.
10.10.2022 | Kuopio Chamber of Commerce
Marginum joins Kuopio Chamber of Commerce and the Finnish Startup Community after winning Tahko Ski Lift Pitch 2022.
4.10.2022 | University of Eastern Finland
Marginum has been nominated by University of Eastern Finland (UEF) to participate at Stage Two competition in Berlin.
13.9.2022 | Kuopio Health
Marginum joined Kuopio Health to further connect with research institutions and other member companies in the medical technology industry.
6.9.2022 | Tekniikka&Talous
Cancerous tissue could be completely removed in the first operation. In this story, we’ll tell you what Marginum’s device is all about.
14.6.2022 | Business Kuopio
Marginum Ltd, founded in autumn 2020, is developing next-generation technology for the removal of cancerous tumours.
27.4.2022 | Finnish Medical Journal
Precision techniques such as Marginum’s aspirate tissue monitoring enable unprecedently efficient identification of cancer tissue and the best possible treatment.
25.4.2022 | Mediuutiset
Contemporary techniques in glioma surgery are limited by their complexity, subjectivity and randomness, resulting in reoperations and suboptimal care.